Who’s Hired? Teva’s Baeder Takes Lead At Apotex In US

As Coherus Searches For A New CFO And Amgen Makes New Executive Appointments

Shortly after departing from her role as Teva’s COO for US generics and biosimilars, Christine Baeder has been named as president of Apotex in the US. Meanwhile, Coherus Biosciences has announced a CFO transition and Amgen has made executive appointments to “accelerate innovation”.

Christine Baeder of Teva and the AAM
Christine Baeder has become president of Apotex in the US • Source: Teva

More from Leadership

More from Generics Bulletin